Brainstorm Cell Therapeutics Inc.

BCLI ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 May 20, 2026 OWNERSHIP DOCUMENT
8-K May 15, 2026 FORM 8-K
10-Q May 15, 2026 10-Q
10-K Mar 31, 2026 10-K
8-K Mar 31, 2026 FORM 8-K
8-K Feb 27, 2026 FORM 8-K
8-K Feb 13, 2026 FORM 8-K
8-K Jan 9, 2026 FORM 8-K
10-Q Nov 14, 2025 10-Q
8-K Nov 14, 2025 FORM 8-K
8-K Nov 6, 2025 FORM 8-K
25-NSE Oct 9, 2025
10-Q Aug 14, 2025 10-Q
8-K Aug 14, 2025 FORM 8-K
RW Jul 22, 2025 RW
8-K Jul 17, 2025 FORM 8-K
S-8 Jul 3, 2025 FORM S-8
S-3 Jun 25, 2025 FORM S-3
8-K Jun 25, 2025 FORM 8-K
8-K Jun 16, 2025 FORM 8-K
8-K May 19, 2025 FORM 8-K
ARS May 16, 2025 ARS
DEFA14A May 16, 2025 DEFA14A
DEF 14A May 16, 2025 DEF 14A
10-Q May 15, 2025 10-Q
← Newer Page 2 of 39 · 952 filings Older →